CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder

被引：0
|
作者：
Guoliang Yang
Lianhua Zhang
Mengyao Liu
Qiang liu
Xuehui Duan
Juanjie Bo
机构：
[1] Shanghai Jiao Tong University,Department of Urology, Ren Ji Hospital, School of Medicine
[2] Shanghai Jiao Tong University,Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine
[3] Shanghai Jiao Tong University,Department of Pathology, Ren Ji Hospital, School of Medicine
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Bladder cancer; T1 high grade; CD163+ macrophage; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2721 / 2726
页数：5
相关论文
共 50 条
  • [41] Intravesical Mitomycin Therapy for Stage T1 and Tis High-Grade Squamous Cell Carcinoma of the Bladder
    Delto, Joan C.
    Kacker, Ravi
    Bubley, Glenn
    DeWolf, William C.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (01) : E35 - E36
  • [42] Outcomes of patients with clinical T1 grade 3 bladder urothelial cell carcinoma treated with radical cystectomy
    Gupta, A.
    Nielsen, M.
    Bastion, P.
    Palapattu, G.
    Vazina, A.
    Lerner, S.
    Schoenberg, M.
    Sagalowsky, A.
    Lotan, Y.
    Shariat, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 26 - 26
  • [43] Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
    Gupta, Amit
    Lotan, Yair
    Bastian, Patrick J.
    Palapattu, Ganesh S.
    Karakiewicz, Pierre I.
    Raj, Ganesh V.
    Schoenberg, Mark P.
    Lerner, Seth P.
    Sagalowsky, Arthur I.
    Shariat, Shahrokh F.
    UROLOGY, 2008, 71 (02) : 302 - 307
  • [44] Genomic landscape of high-grade T1 micropapillary bladder tumors.
    Bellmunt, Joaquim
    Guo, Guangwu
    Mullane, Stephanie A.
    Orsola, Anna
    Werner, Lillian
    Van Hummelen, Paul
    Thorner, Aaron
    Loda, Massimo
    Choueiri, Toni K.
    Barletta, Justine A.
    Kwiatkowski, David J.
    Meyerson, Matthew
    Van Allen, Eliezer Mendel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [45] Optimal timing of radical cystectomy in T1 high-grade bladder cancer
    Bostroem, Peter J.
    Alkhateeb, Sultan
    van Rhijn, Bas W. G.
    Kuk, Cynthia
    Zlotta, Alexandre R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (12) : 1891 - 1902
  • [46] Results of second transurethral resection for high-grade T1 bladder cancer
    Hashine, Katsuyoshi
    Ide, Takehiro
    Nakashima, Takeshi
    Hosokawa, Tadanori
    Ninomiya, Iku
    Teramoto, Norihiro
    UROLOGY ANNALS, 2016, 8 (01) : 10 - 15
  • [47] T1 High-grade Bladder Cancer: The Search for the Optimal Management Continues
    Mostafid, Hugh
    Palou, Joan
    Burger, Maximilian
    Babjuk, Marko
    EUROPEAN UROLOGY, 2018, 74 (05) : 609 - 610
  • [48] Cystectomy in high-grade T1 bladder cancer: Often too early?
    Klan, R
    Steiner, U
    Sauter, T
    Hardung, R
    Miller, K
    AKTUELLE UROLOGIE, 1998, 29 (02) : 53 - 55
  • [49] Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
    Chen, Xiaonan
    Wu, Bin
    Xu, Zhenqun
    Li, Shijie
    Tan, Shutao
    Liu, Xuefeng
    Wang, Kefeng
    CANCER MEDICINE, 2016, 5 (08): : 1856 - 1862
  • [50] Micropapillary Urothelial Carcinoma of the Bladder: Clinicopathologic Analysis of Patients with T1 Disease
    Huang, H.
    Spaliviero, M.
    Dalbagni, G.
    Bochner, B. H.
    Sfakianos, J. P.
    Donat, S. M.
    Herr, H. W.
    Chen, Y-B
    Gopalan, A.
    Fine, S. W.
    Tickoo, S. K.
    Reuter, V. E.
    Al-Ahmadie, H. A.
    MODERN PATHOLOGY, 2014, 27 : 236A - 236A
12345